• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

iScience launches Web site for surgeons

Article

iScience Interventional has launched a new surgeon support Web site, called iForum, that can be viewed at www.iforummd.com, according to a release issued by the company.

Menlo Park, CA

-iScience Interventional has launched a new surgeon support Web site, called iForum, that can be viewed at

www.iforummd.com

, according to a release issued by the company.

The Web site is open to all registered physicians who are trained in canaloplasty and have incorporated the procedure into their treatment armamentarium for patients with primary open-angle glaucoma (POAG), and it is designed to provide these surgeons with a resource center and forum for peer-to-peer interaction on the new technique.

According to the company, features of the site include a chat room and message board (in which the physicians can share their experiences and ask questions), Web seminars, and procedure video footage. Users also will have access to clinical materials and resources designed to help keep them current on the latest advances and patient education tools concerning the procedure as well as to podcasts of recent presentations by leaders within the canaloplasty community.

“We are pleased to establish this online community for ophthalmologists as they embark on the adoption of interventional platforms into their surgical practice,” said Mike Nash, co-founder and president of iScience Interventional. “iScience is committed to providing a support network for surgeons as they embrace microcatheter-based procedures and ultimately deliver the benefits of these procedures to their patients.”

Canaloplasty is a minimally invasive procedure that is safe and effective in lowering IOP and reducing medication dependence in patients with POAG, according to the statement.

Related Videos
 John Bladen, MBBS, BSc, MRCS, PGCert, PhD, FRCOphth, consultant ophthalmologist and oculoplastic surgeon, King's College Hospital NHS Foundation Trust, London, UK, speaks with Ophthalmology Times Europe's® Caroline Richards
rande, CFP, and John S. Grande, CFP, of Grande Financial Services, continue their discussion with Ophthalmology Times®' Sheryl Stevenson
What keeps you up at night?
S.K. Steven Houston III, MD, discusses retina innovations in use in his practice, including the NGENUITY 1.4 upgrade from Alcon
Caesar Luo, MD, shares his key take-aways on diabetic retinopathy progression in anti-VEGF versus FA implant
© 2024 MJH Life Sciences

All rights reserved.